With international corporate M&A and private equity being the hallmark of the firm, William Fry LLP displays an impressive roster of clients in the sector, working with some of the world’s largest corporates. Spearheaded by M&A heavyweight Ivor Banim, the London office advises on complex transactional work, regularly working in conjunction with the firm’s offices in Cork and Dublin. The firm also displays expertise in real estate, particularly in the retail and leisure sector, as well as in public sector work; the firm is often found advising the State on high-value, multijurisdictional issues. Other key figures include Brian Butterwick, rated by clients as a ‘very solid operator’, and Aisling O’Gorman, noted for her expertise in renewable energy work, and wind power in particular.
Testimonials
Collated independently by Legal 500 research team.
- 'Complete experts in Irish law coupled with responsiveness and excellent client service.'
- 'Brian Butterwick is a very solid operator - knowledgeable, responsive and just generally easy to work with.'
Key clients
- Amgen
- SoftBank
- AIB
- Tesco
- DCC plc
- Edwards Lifesciences plc
- Glanbia
- York Capital Management
- Lazard Asset Management
- Mayfair Equity Partners
- Value Retail
- Phoenix Group
- Barclays Bank plc
- Uniphar plc
- U and I Group PLC (formerly Development Securities plc)
- Sands Capital
- Davy Group
- Goodbody
- RBC Capital Markets
- Yew Grove REIT
- Pollen Street Capital
- Towerbrook Capital
- August Equity Partners
- Gresham House Asset Management
- Medivet Group
- Clayton Dubilier & Rice
- New Mountain Capital
- Aceto Group
- Wealth at Work Group
- Kyndryl Group
- Nordic Aviation
- Mercer
- Amarenco Solar
- Copenhagen Infrastructure Partners
- UKG Group
Work highlights
- Advised UKG Inc. the United States based software-computer company on the acquisition of Immedis Limited and its subsidiaries for a reported €575 million.
- Advised Amgen, one of the world's leading independent biotechnology companies, on its acquisition of Horizon Therapeutics plc, a global biotechnology company headquartered in Dublin, for an enterprise value of $28.3 billion.
- Advised the Irish Department of Finance on (i) the sale by the State of approximately 10% of AIB Group plc by way of two separate accelerated book built placings, raising gross proceeds of approximately €995m; and (ii) on the sale of 5% of permanentTSB by way of an accelerated book-built placing to institutional investors.
Lawyers
Practice head
The lawyer(s) leading their teams.
Ivor Banim